Padagis Discontinued
FDA Approved Drugs
Padagis Discontinued
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 40
- Latest Approval Date Apr 03, 2026
- Data Source FDA
- First Approval Date Jan 01, 1982
Company Overview
Social Profiles
Company Snapshot
Padagis Discontinued
Zvi Bornstein str. PO Box: 80500 Old Industrial Park, Yerucham 16
Israel
padagis.com/ View on MapFDA Approved Drug Records ( 40 records )
Drug Name
AZELASTINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.137MG/SPRAY
Approval Date
2017-03-17
Active Ingredient
AZELASTINE HYDROCHLORIDE
Application Number
202609
Product Number
1
Dosage Form
-
Strength
0.137MG/SPRAY
Approval Date
2017-03-17
Regulatory Status
Discontinued
Drug Name
BACITRACIN
Product Number
1
Dosage Form
-
Strength
500 UNITS/GM
Approval Date
1982-01-01
Active Ingredient
BACITRACIN
Application Number
61212
Product Number
1
Dosage Form
-
Strength
500 UNITS/GM
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
BACITRACIN ZINC AND POLYMYXIN B SULFATE
Product Number
1
Dosage Form
-
Strength
500 UNITS/GM;10,000 UNITS/GM
Approval Date
2002-02-27
Active Ingredient
BACITRACIN ZINC; POLYMYXIN B SULFATE
Application Number
65022
Product Number
1
Dosage Form
-
Strength
500 UNITS/GM;10,000 UNITS/GM
Approval Date
2002-02-27
Regulatory Status
Discontinued
Drug Name
BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE
Product Number
2
Dosage Form
-
Strength
400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
Approval Date
1982-01-01
Active Ingredient
BACITRACIN ZINC; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Application Number
62166
Product Number
2
Dosage Form
-
Strength
400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
BETAMETHASONE DIPROPIONATE
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE
Approval Date
2017-11-09
Active Ingredient
BETAMETHASONE DIPROPIONATE
Application Number
206118
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE
Approval Date
2017-11-09
Regulatory Status
Discontinued
Drug Name
BRINZOLAMIDE
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2023-07-28
Active Ingredient
BRINZOLAMIDE
Application Number
211914
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2023-07-28
Regulatory Status
Discontinued
Drug Name
BUTOCONAZOLE NITRATE
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
1997-02-07
Active Ingredient
BUTOCONAZOLE NITRATE
Application Number
19881
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
1997-02-07
Regulatory Status
Discontinued
Drug Name
CALCIUM ACETATE
Product Number
1
Dosage Form
-
Strength
667MG
Approval Date
2011-04-13
Active Ingredient
CALCIUM ACETATE
Application Number
91561
Product Number
1
Dosage Form
-
Strength
667MG
Approval Date
2011-04-13
Regulatory Status
Discontinued
Drug Name
CENTANY
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
2002-12-04
Active Ingredient
MUPIROCIN
Application Number
50788
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
2002-12-04
Regulatory Status
Discontinued
Drug Name
CLINDA-DERM
Product Number
1
Dosage Form
-
Strength
EQ 1% BASE
Approval Date
1992-09-30
Active Ingredient
CLINDAMYCIN PHOSPHATE
Application Number
63329
Product Number
1
Dosage Form
-
Strength
EQ 1% BASE
Approval Date
1992-09-30
Regulatory Status
Discontinued
Drug Name
CLINDAMYCIN PALMITATE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 75MG BASE/5ML
Approval Date
2010-07-07
Active Ingredient
CLINDAMYCIN PALMITATE HYDROCHLORIDE
Application Number
90902
Product Number
1
Dosage Form
-
Strength
EQ 75MG BASE/5ML
Approval Date
2010-07-07
Regulatory Status
Discontinued
Drug Name
CLOBETASOL PROPIONATE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2011-06-16
Active Ingredient
CLOBETASOL PROPIONATE
Application Number
90898
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2011-06-16
Regulatory Status
Discontinued
Drug Name
CYCLOSPORINE
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
2003-10-07
Active Ingredient
CYCLOSPORINE
Application Number
65151
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
2003-10-07
Regulatory Status
Discontinued
Drug Name
DESONIDE
Product Number
1
Dosage Form
-
Strength
0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
DESONIDE
Application Number
17010
Product Number
1
Dosage Form
-
Strength
0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
DESOXIMETASONE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2006-01-09
Active Ingredient
DESOXIMETASONE
Application Number
77552
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2006-01-09
Regulatory Status
Discontinued
Drug Name
DIHYDROERGOTAMINE MESYLATE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2003-04-28
Active Ingredient
DIHYDROERGOTAMINE MESYLATE
Application Number
40475
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2003-04-28
Regulatory Status
Discontinued
Drug Name
EFINACONAZOLE
Product Number
1
Dosage Form
-
Strength
10%
Approval Date
2020-12-16
Active Ingredient
EFINACONAZOLE
Application Number
211851
Product Number
1
Dosage Form
-
Strength
10%
Approval Date
2020-12-16
Regulatory Status
Discontinued
Drug Name
ERYTHROMYCIN
Product Number
1
Dosage Form
-
Strength
0.5%
Approval Date
1983-09-26
Active Ingredient
ERYTHROMYCIN
Application Number
62447
Product Number
1
Dosage Form
-
Strength
0.5%
Approval Date
1983-09-26
Regulatory Status
Discontinued
Drug Name
ESTRADIOL
Product Number
1
Dosage Form
-
Strength
0.06% (1.25GM/ACTIVATION)
Approval Date
2026-02-02
Active Ingredient
ESTRADIOL
Application Number
215096
Product Number
1
Dosage Form
-
Strength
0.06% (1.25GM/ACTIVATION)
Approval Date
2026-02-02
Regulatory Status
Discontinued
Drug Name
GENTAMICIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 0.3% BASE
Approval Date
2004-01-30
Active Ingredient
GENTAMICIN SULFATE
Application Number
65121
Product Number
1
Dosage Form
-
Strength
EQ 0.3% BASE
Approval Date
2004-01-30
Regulatory Status
Discontinued
Drug Name
GLYCOPYRRONIUM TOSYLATE
Product Number
1
Dosage Form
-
Strength
EQ 2.4% BASE
Approval Date
2026-04-03
Active Ingredient
GLYCOPYRRONIUM TOSYLATE
Application Number
214448
Product Number
1
Dosage Form
-
Strength
EQ 2.4% BASE
Approval Date
2026-04-03
Regulatory Status
Discontinued
Drug Name
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
Product Number
1
Dosage Form
-
Strength
1.5MG/5ML;5MG/5ML
Approval Date
2017-02-15
Active Ingredient
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
Application Number
205731
Product Number
1
Dosage Form
-
Strength
1.5MG/5ML;5MG/5ML
Approval Date
2017-02-15
Regulatory Status
Discontinued
Drug Name
HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/5ML;60MG/5ML
Approval Date
2014-04-29
Active Ingredient
HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
Application Number
204658
Product Number
1
Dosage Form
-
Strength
5MG/5ML;60MG/5ML
Approval Date
2014-04-29
Regulatory Status
Discontinued
Drug Name
HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
4MG/5ML;5MG/5ML;60MG/5ML
Approval Date
2014-04-29
Active Ingredient
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
Application Number
204627
Product Number
1
Dosage Form
-
Strength
4MG/5ML;5MG/5ML;60MG/5ML
Approval Date
2014-04-29
Regulatory Status
Discontinued
Drug Name
KETOCONAZOLE
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
2021-11-17
Active Ingredient
KETOCONAZOLE
Application Number
215185
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
2021-11-17
Regulatory Status
Discontinued
Drug Name
MORPHINE SULFATE
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2012-08-06
Active Ingredient
MORPHINE SULFATE
Application Number
201574
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2012-08-06
Regulatory Status
Discontinued
Drug Name
NARATRIPTAN
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2010-07-08
Active Ingredient
NARATRIPTAN HYDROCHLORIDE
Application Number
91326
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2010-07-08
Regulatory Status
Discontinued
Drug Name
NARATRIPTAN
Product Number
2
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2010-07-08
Active Ingredient
NARATRIPTAN HYDROCHLORIDE
Application Number
91326
Product Number
2
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2010-07-08
Regulatory Status
Discontinued
Drug Name
NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC
Product Number
2
Dosage Form
-
Strength
400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM
Approval Date
1982-01-01
Active Ingredient
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Application Number
60764
Product Number
2
Dosage Form
-
Strength
400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
Product Number
1
Dosage Form
-
Strength
0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
Approval Date
1989-07-31
Active Ingredient
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Application Number
62938
Product Number
1
Dosage Form
-
Strength
0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
Approval Date
1989-07-31
Regulatory Status
Discontinued
Drug Name
PILOCARPINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2004-11-16
Active Ingredient
PILOCARPINE HYDROCHLORIDE
Application Number
76746
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2004-11-16
Regulatory Status
Discontinued
Drug Name
POTASSIUM CHLORIDE
Product Number
1
Dosage Form
-
Strength
8MEQ
Approval Date
2011-05-18
Active Ingredient
POTASSIUM CHLORIDE
Application Number
200185
Product Number
1
Dosage Form
-
Strength
8MEQ
Approval Date
2011-05-18
Regulatory Status
Discontinued
Drug Name
POTASSIUM CHLORIDE
Product Number
2
Dosage Form
-
Strength
10MEQ
Approval Date
2011-05-18
Active Ingredient
POTASSIUM CHLORIDE
Application Number
200185
Product Number
2
Dosage Form
-
Strength
10MEQ
Approval Date
2011-05-18
Regulatory Status
Discontinued
Drug Name
REPAGLINIDE
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
2013-07-17
Active Ingredient
REPAGLINIDE
Application Number
201189
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
2013-07-17
Regulatory Status
Discontinued
Drug Name
REPAGLINIDE
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
2014-01-22
Active Ingredient
REPAGLINIDE
Application Number
201189
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
2014-01-22
Regulatory Status
Discontinued
Drug Name
REPAGLINIDE
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
2014-01-22
Active Ingredient
REPAGLINIDE
Application Number
201189
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
2014-01-22
Regulatory Status
Discontinued
Drug Name
STIE-CORT
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
1985-11-25
Active Ingredient
HYDROCORTISONE
Application Number
89066
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
1985-11-25
Regulatory Status
Discontinued
Drug Name
SULFACETAMIDE SODIUM
Product Number
1
Dosage Form
-
Strength
10%
Approval Date
1982-01-01
Active Ingredient
SULFACETAMIDE SODIUM
Application Number
80029
Product Number
1
Dosage Form
-
Strength
10%
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
TAVABOROLE
Product Number
1
Dosage Form
-
Strength
5%
Approval Date
2020-10-13
Active Ingredient
TAVABOROLE
Application Number
211848
Product Number
1
Dosage Form
-
Strength
5%
Approval Date
2020-10-13
Regulatory Status
Discontinued
Drug Name
TRIPLE SULFA
Product Number
1
Dosage Form
-
Strength
3.7%;2.86%;3.42%
Approval Date
1982-11-15
Active Ingredient
TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)
Application Number
87285
Product Number
1
Dosage Form
-
Strength
3.7%;2.86%;3.42%
Approval Date
1982-11-15
Regulatory Status
Discontinued
Drug Status Breakdown
40 total- Discontinued
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
AZELASTINE HYDROCHLORIDE
Application Number
202609
Product Number
1
Active Ingredient
AZELASTINE HYDROCHLORIDE
Dosage Form
-
Strength
0.137MG/SPRAY
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.